Intelligence · Clinical pipeline
Infectious disease R&D Pipeline
Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Quick answer
Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Top sponsors
- United Therapeutics Europe 94 programs
- BRIGHT MINDS BIOSCIENCES 81 programs
- Chinese Academy of 77 programs
- Sinovac Research and 49 programs
- GSK Glaxo Smith 39 programs
- Takeda 33 programs
- First People's Hospital 31 programs
- Vertex Pharmaceuticals (Australia) 30 programs
- Vir Biotechnology 26 programs
- George Institute for 25 programs
- ENANTA PHARMACEUTICALS 22 programs
- Hospital Authority 22 programs
Pipeline programs
-
HIPRA-HH-17
Hipra Human Health S.L.
COVID-19
1 trial -
Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Healive+Healive
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Healive® Lot 1
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
High-dosage SARS-CoV-2 vaccine
Sinovac Research and Development Co.,
COVID-19
1 trial -
Honghe Fujie lotion
The First People's Hospital of Lianyungang
Bacterial Vaginitis
1 trial -
IXCHIQ
Ars Pharmaceuticals Irl Limited
Chikungunya Virus Infection
1 trial -
Imipenem
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Inactivated COVID-19 vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Inactivated HAV vaccine
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Inactivated Hepatitis A vaccine (HAV)
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2
Sinovac Research and Development Co.,
COVID-19
1 trial -
Inactivated SARS-CoV-2 Vaccine (Vero cell）
Sinovac Research and Development Co.,
COVID-19
1 trial -
Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2 Infection
1 trial -
Investigational 23-valent PPV
Sinovac Research and Development Co.,
Pneumococcal Infections
2 trials -
Isoniazid Aminosalicylate Tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Reinfection Pulmonary Tuberculosis
1 trial -
Keverprazan
The First People's Hospital of Lianyungang
H. Pylori Infection
1 trial -
LINEZOLID, LINEZOLID
The George Institute
Sepsis
1 trial -
LIVTENCITY 200 mg film-coated tablets.
The George Institute
Transplant patients with high recurrent Epstein-Barr infection
1 trial -
Levofloxacin
Hospital Authority, Hong Kong
Urinary Tract Infection
1 trial -
Longidaza
The First People's Hospital of Lianyungang
Bacterial Vaginosis
1 trial -
Mecobalamin
Sichuan Provincial People's Hospital
Sepsis
1 trial -
Methylprednisolone and Mycophenolate mofetil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Hepatitis
1 trial -
Metronidazole
Hospital Authority, Hong Kong
Helicobacter Pylori Infection
1 trial -
Metronidazole vaginal suppositories
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bacterial Vaginosis
1 trial -
Nafamostat mesilate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Norfloxacino Sandoz 400 mg comprimidos EFG
The George Institute
Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.
1 trial -
OM 85OLDER
Fondazione Telethon ETS
Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.
1 trial -
Oral Methamphetamine
BRIGHT MINDS BIOSCIENCES INC.
HIV-1-infection
1 trial -
PEG-IFN alfa-2a
Hoffmann-La Roche
Hepatitis C, Chronic
1 trial -
PI21/004444
The George Institute
Latent tuberculosis infection in patients with end-stage kidney disease.
1 trial -
PLACEBO, ISMIGEN tabletki podjezykowe
Lacuna Pharma Pty Ltd
Respiratory Tract Infections
1 trial -
PREDICT study
The George Institute
Cardiovascular device infections
1 trial -
PRO-HAV-MA4001-LN
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
PRO-QINF-4001
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-4010
Sinovac Research and Development Co.,
COVID-19
1 trial -
PYTEST® 14C-Urea Breath Test
Phathom Pharmaceuticals
H Pylori Infection
1 trial -
PYTEST® 14C-Urea Capsule Breath Test (at Home)
Phathom Pharmaceuticals
H. Pylori Infection
1 trial -
Peginterferon alfa
Third Affiliated Hospital, Sun Yat-Sen University
Chronic Hepatitis B
1 trial -
Peginterferon alfa-2a
Vera Therapeutics
Hepatitis B, Chronic
1 trial -
Pfizer-BioNTech mRNA COVID-19 vaccine
BRIGHT MINDS BIOSCIENCES INC.
COVID -19
1 trial -
Pharmacotherapy for opioid use disorder
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Pidotimod
Almirall, S.A.
Recurrent Respiratory Tract Infections
1 trial -
Pioglitazone
Takeda
Nonalcoholic Steatohepatitis
1 trial -
Prevenar 13
United Therapeutics Europe Ltd
Sepsis
1 trial -
Raltegravir
Merck KGaA, Darmstadt, Germany
Human Immunodeficiency Virus (HIV) Infection
1 trial -
Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)
United Therapeutics Europe Ltd
Diarrhea
1 trial
Frequently asked questions
How many infectious disease pipeline programs are tracked?
1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.